QUIDEL CORP /DE/
S-8, 1996-08-20
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: IAA TRUST MONEY MARKET FUND INC, DEF 14A, 1996-08-20
Next: QUIDEL CORP /DE/, S-8, 1996-08-20



<PAGE>   1
    As filed with the Securities and Exchange Commission on August 20, 1996

                                                   Registration No. 333-________
================================================================================

                       SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C. 20549
                             
                            -----------------------
                            
                                    FORM S-8

                             REGISTRATION STATEMENT
                                     UNDER
                           THE SECURITIES ACT OF 1933
                            
                            -----------------------
                            
                               QUIDEL CORPORATION
             (Exact name of Registrant as specified in its charter)

           DELAWARE                                    94-2573850
(State or other jurisdiction of                     (I.R.S. Employer 
 incorporation or organization)                     Identification No.)
 
                            -----------------------

                              10165 MCKELLAR COURT
                          SAN DIEGO, CALIFORNIA 92121
                                 (619) 552-1100
              (Address, including zip code, and telephone number,
       including area code, of Registrant's Principal Executive Offices)

                            -----------------------

                       1983 EMPLOYEE STOCK PURCHASE PLAN
                             (Full Title of Plan)   

                            -----------------------

                               STEVEN T. FRANKEL
                     PRESIDENT AND CHIEF EXECUTIVE OFFICER
                               QUIDEL CORPORATION
                              10165 MCKEILAR COURT
                          SAN DIEGO, CALIFORNIA 92121
                                 (619) 552-1100
          (Name, address, including zip code, and telephone number,
                  including area code, of agent for service)

                            -----------------------
 
                        CALCULATION OF REGISTRATION FEE
<TABLE>
<CAPTION>
===========================================================================================================
                                                               PROPOSED         PROPOSED
                                                               MAXIMUM          MAXIMUM
                                            AMOUNT             OFFERING         AGGREGATE       AMOUNT OF
         TITLE OF SECURITIES                TO BE              PRICE PER        OFFERING       REGISTRATION
          TO BE REGISTERED               REGISTERED(1)         SHARE(2)         PRICE(2)           FEE
- -----------------------------------------------------------------------------------------------------------
 <S>          <C>                       <C>                    <C>              <C>              <C>
 COMMON STOCK, $.001 PAR VALUE          100,000 SHARES         $4.375           $437,500         $150.86
===========================================================================================================
</TABLE>

(1)  There is also being registered hereunder such additional undetermined
     number of shares of Common Stock that may be issued from time to time as a
     result of the anti-dilution provisions of the Plan.

(2)  Estimated solely for the purpose of calculating the registration fee
     pursuant to Rules 457(h) and 457(c) and based on the high and low prices
     of the Common Stock of Quidel Corporation as reported on August 16, 1996
     on the NASDAQ National Market System.

===============================================================================

                                       1



<PAGE>   2



                                  INTRODUCTION
                                  ------------

         This Registration Statement on Form S-8 is filed by Quidel
Corporation, a Delaware corporation (the "Company") relating to an additional
100,000 shares of the Company's common stock, par value $.001 per share (the
"Common Stock"), issuable under the Company's 1983 Employee Stock Purchase Plan
(the "Plan"), and consists of only those items required by General Instruction
E to Form S-8.


            INCORPORATION OF PREVIOUSLY FILED REGISTRATION STATEMENT
            --------------------------------------------------------

         The contents of the Registration Statement on Form S-8, Registration
No. 33-33562, previously filed with the Securities and Exchange Commission on
February 16, 1990 by the Company under the name Monoclonal Antibodies, Inc.,
are incorporated herein by reference and made a part hereof.


ITEM 8. EXHIBITS.

         4.1     Certificate of Incorporation of the Company, as amended (filed
                 as Exhibit 3.1 to the Company's Current Report on Form 8-K
                 dated February 26, 1991, and incorporated herein by reference)

         4.2     Certificate of Designations of the Series B Preferred Stock of
                 the Company (filed as Exhibit 4.1 to the Company's Current
                 Report on Form 8-K dated January 5, 1995, and incorporated
                 herein by reference)

         4.3     Amended and Restated Bylaws of the Company (filed as Exhibit
                 3.2 to the Company's Current Report on Form 8-K dated June 16,
                 1995, and incorporated herein by reference)

         5       Opinion of Gibson, Dunn & Crutcher LLP as to the legality of
                 the securities being registered

         23.1    Consent of Ernst & Young LLP, independent auditors

         23.2    Consent of Counsel (contained in Exhibit 5 hereto)

         24      Power of Attorney (contained on signature page hereto)





                                       2
<PAGE>   3
                                   SIGNATURES


         Pursuant to the requirements of the Securities Act of 1933, the
Company certifies that it has reasonable grounds to believe that it meets all
of the requirements for a filing on Form S-8 and has duly caused this
registration statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in the City of San Diego, State of California, on August 6,
1996.


                                        QUIDEL CORPORATION


                                        By:  /s/  STEVEN T. FRANKEL
                                            ----------------------------------
                                                  Steven T. Frankel
                                                  President and Chief
                                                  Executive Officer


                               POWER OF ATTORNEY

         Each person whose signature appears below constitutes and appoints
STEVEN T. FRANKEL and STEVEN C. BURKE his or her true and lawful
attorneys-in-fact and agents, each acting alone, with full powers of
substitution and resubstitution, for him or her and in his or her name, place
and stead, in any and all capacities, to sign any and all amendments (including
post-effective amendments) to this Registration Statement and to file the same,
with all exhibits thereto, and other documents in connection therewith, with
the Securities and Exchange Commission, granting unto said attorneys-in-fact
and agents, each acting alone, with full powers and authority to do and perform
each and every act and thing requisite and necessary to be done in and about
the premises, as full to all intents and purposes as he or she might or could
do in person, hereby ratifying and confirming that all said attorneys-in-fact
and agents, each acting alone, or his substitute or substitutes, may lawfully
do or cause to be done by virtue hereof.

         Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons in the
capacities indicated on the date indicated.


<TABLE>
<CAPTION>

         SIGNATURE                               TITLE                              DATE
         ---------                              ------                              ----
 <S>                                      <C>                                      <C>   
  /s/ RICHARD C.E. MORGAN                 Chairman of the Board                  August 6, 1996
- ----------------------------------
      Richard C.E. Morgan



 /s/  STEVEN T. FRANKEL              President and Chief Executive Officer       August 6, 1996
- ----------------------------------       (Principal Executive Officer)                                          
      Steven T. Frankel                           and Director         
                                                                       



 /s/  STEVEN C. BURKE                     Vice President-Finance and             August 6, 1996
- ----------------------------------    Administration and Chief Financial                               
      Steven C. Burke                  Officer (Principal Financial and
                                              Accounting Officer)                                   
                                          


 /s/  JOHN D. DIEKMAN, Ph.D.                       Director                      August 6, 1996
- ----------------------------------                                                                         
      John D. Diekman, Ph.D.


 /s/  THOMAS A. GLAZE                              Director                      August 6, 1996
- ----------------------------------                                                                                
      Thomas A. Glaze
</TABLE>





                                       3
<PAGE>   4

<TABLE>

 <S>                                               <C>                           <C>
 /s/  MARY LAKE POLAN, M.D., Ph.D.                 Director                      August 6, 1996
- ----------------------------------                                                                    
      Mary Lake Polan, M.D., Ph.D



 /s/  FAYE WATTLETON                               Director                      August 6, 1996
- ----------------------------------                                                                                 
      Faye Wattleton


 /s/  ROGER F. GREAVES                             Director                      August 6, 1996
- ----------------------------------                                                                               
      Roger F. Greaves


 /s/  ROCKELL N. HANKIN                            Director                      August 6, 1996
- ----------------------------------                                                                              
      Rockell N. Hankin



 /s/  MARGARET G. McGLYNN, R.Ph.                   Director                      August 7, 1996
 ---------------------------------                                                                      
      Margaret G. McGlynn, R.Ph.
</TABLE>





                                       4
<PAGE>   5

                                 EXHIBIT INDEX


<TABLE>
<CAPTION>
       Exhibit No.       Description

       -----------       -----------
         <S>             <C>
         4.1*            Certificate of Incorporation of the Company, as amended

         4.2*            Certificate of Designations of the Series B Preferred Stock of the Company

         4.3*            Amended and Restated Bylaws of the Company

         5               Opinion of Gibson, Dunn & Crutcher LLP as to the legality of the securities being
                         registered

         23.1            Consent of Ernst & Young LLP, independent auditors

         23.2            Consent of Gibson, Dunn & Crutcher LLP (contained in Exhibit 5 hereto)

         24              Power of Attorney (contained on signature page hereof)
</TABLE>

- ---------------

*  Incorporated herein by reference.  See sequentially numbered page 2.
                  
                  
                  
                                       5

<PAGE>   1
                                                                       EXHIBIT 5


                    [Gibson, Dunn & Crutcher LLP Letterhead]

                                August 16, 1996


Quidel Corporation
10165 McKellar Court
San Diego, California 92121



          Re:   Registration Statement on Form S-8 of 100,000 Shares
                of Common Stock



Ladies and Gentlemen:

         We have acted as your counsel in the preparation of a Registration
Statement on Form S-8 (the "Registration Statement") to be filed with the
Securities and Exchange Commission to register 100,000 shares of common stock,
par value $.001 per share (the "Common Stock") of Quidel Corporation, a
Delaware corporation (the "Company"), to be issued pursuant to the Company's
1983 Employee Stock Purchase Plan (the "Plan").

         For purposes of rendering this opinion, we have made such legal and
factual examinations as we have deemed necessary under the circumstances and,
as part of such examinations, we have examined, among other things, originals
and copies, certified or otherwise, identified to our satisfaction, of such
documents, corporate records and other instruments as we have deemed necessary
or appropriate.  For the purposes of such examinations, we have assumed the
genuineness of all signatures on original documents and the conformity to
original documents of all copies submitted to us.

         On the basis of and in reliance upon the foregoing examinations and
assumptions, we are of the opinion that, assuming the Registration Statement
shall have become effective pursuant to the provisions of the Securities Act of
1933, as amended, the shares of Common Stock being offered under the Plan, when
issued in accordance with the Registration Statement and the provisions of the
Plan, will be validly issued, fully paid and nonassessable.

         We hereby consent to the filing of this opinion as an exhibit to the
Registration Statement.


                                          Very truly yours,


                                          /s/ GIBSON, DUNN & CRUTCHER LLP
                                          -------------------------------
                                              Gibson, Dunn & Crutcher LLP

EMG/MDL





                                       6


<PAGE>   1
                                                                    EXHIBIT 23.1




               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS


         We hereby consent to the incorporation by reference in the Registration
Statement on Form S-8 and related prospectus pertaining to the Quidel
Corporation 1983 Employee Stock Purchase Plan of our report dated May 3, 1996,
with respect to the consolidated financial statements of Quidel Corporation
incorporated by reference in its Annual Report on Form 10-K for the year ended
March 31, 1996, filed with the Securities and Exchange Commission.




Ernst & Young LLP




San Diego, California
August 15, 1996







                                       7


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission